Amgen Inc. issued $4 billion in aggregate principal amount of senior notes across four tranches with maturities ranging from 2031 to 2056, generating approximately $3.96 billion in net proceeds. The notes carry interest rates between 4.200% and 5.650% per annum, providing the company with significant liquidity while increasing its long-term debt and interest expense.
